Treats mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin…. ANDA 90132, held by Sun Pharmaceutical Industries. Carvedilol Phosphate.
As of Nov 21, 2026, ANDA 90132 (Carvedilol Phosphate), held by Sun Pharmaceutical Industries, was first approved by FDA on Oct 25, 2017, with 2 approved supplements and 0 published complete response letters.
Carvedilol phosphate extended-release capsules are an alpha-/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure. left ventricular dysfunction following myocardial infarction in clinically stable patients. hypertension 1.1 Heart Failure Carvedilol phosphate extended-release capsules are indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization. 1.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 25, 2017 | Original application | Approved |
| Carvedilol Phosphate10MG · capsule, extended release;oral | Carvedilol Phosphate | Rx |
| Carvedilol Phosphate20MG · capsule, extended release;oral | Carvedilol Phosphate | Rx |
| Carvedilol Phosphate40MG · capsule, extended release;oral | Carvedilol Phosphate | Rx |
| Carvedilol Phosphate80MG · capsule, extended release;oral | Carvedilol Phosphate | Rx |
| Apr 16, 2024 | Supplement 5Labeling · Standard review | Approved | None posted |
| Apr 16, 2024 | Supplement 2Labeling · Standard review | Approved | None posted |
| Oct 25, 2017 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters